voriconazole has been researched along with Hematologic Malignancies in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (0.90) | 18.2507 |
2000's | 27 (24.32) | 29.6817 |
2010's | 69 (62.16) | 24.3611 |
2020's | 14 (12.61) | 2.80 |
Authors | Studies |
---|---|
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS | 1 |
Mehta, J; Pennick, G; Pi, J; Scheetz, MH; Trifilio, SM; Yarnold, PR | 1 |
Carlesse, F; Colombo, AL; Kontoyiannis, DP; Nobrega de Almeida, J; Rossato, L | 1 |
Bai, Y; Fan, XH; Hu, CJ; Ji, J; Li, M; Li, Q; Tan, L; Tan, R; Wen, ZP; Xia, BY; Yang, CL; Yang, JH; Yang, Y; Zhang, H; Zheng, XL; Zheng, ZC | 1 |
Ergon, MC; Ertem, O; Gumustekin, M; Oren, H; Tufekci, O; Tuncok, Y | 1 |
Chaphekar, N; Cheng, Y; Huang, H; Huang, W; Liu, M; Wu, X; Zheng, Y | 1 |
Hashimoto, T; Hiramatsu, K; Itoh, H; Maeda, Y; Ogata, M; Takano, K; Tanaka, R; Tatsuta, R | 1 |
Cesaro, S; Cornely, OA; Falces-Romero, I; Kindo, AJ; Klimko, N; Koehler, P; Kredics, L; Lass-Flörl, C; Meyer, E; Racil, Z; Sal, E; Salmanton-García, J; Seidel, D; Stemler, J; Wisplinghoff, H; Würstl, B | 1 |
Doki, N; Fukushima, K; Funata, N; Hishima, T; Horiguchi, SI; Igarashi, A; Inamoto, K; Kaito, S; Kakihana, K; Kishida, Y; Kobayashi, T; Konishi, T; Kurosawa, S; Nagata, A; Najima, Y; Ohashi, K; Sakamaki, H; Sekiya, N; Shimizu, H; Shingai, N; Shirane, S; Toya, T; Uchida, T; Yamada, Y; Yoshifuji, K | 1 |
Cai, R; Li, C; Liu, T; Lv, C; Qi, J; Wei, Y; Wu, D; Wu, Y; Zhou, S | 1 |
Aguado, JM; Azanza, JR; Barberán, J; Cubillo Gracian, A; Dueñas Gutiérrez, C; Fortún, J; García-Vidal, C; González-Sierra, P; Gudiol, C; Kwon, M; Mensa, J; Olave Rubio, T; Pérez de Oteyza, J; Rovira Tarrats, M; Ruiz Camps, I; Salavert Lletí, M; Solano, C; Suárez-Lledó Grande, M; Vázquez, L; Yáñez, L | 1 |
Aguilar-Zapata, D; Barragán-Reyes, A; Camacho, A; Cendejas, RF; Cornejo-Juárez, P; Guzmán, JMF; Hernández, MLG; Jácome, LEL; Juárez-Hernández, E; Nava-Ruiz, A; Ontañón-Zurita, D; Perales-Martínez, D; Reséndiz-Sánchez, J; Rincón-Zuno, J; Rivera-Martínez, NE | 1 |
Aquino, V; Borges, R; Meneghello Fuentefria, A; Ramirez-Castrillon, M; Rosa, PDD; Zubaran Goldani, L | 1 |
Azoulay, E; Calvet, L; Darmon, M; De Jong, A; Kerhuel, L; Lemiale, V; Mokart, D; Moreau, AS; Pardo, E; Stoclin, A; Valade, S | 1 |
Busca, A; Calore, E; Candoni, A; Capelli, D; Castagnola, C; Cattaneo, C; Del Principe, MI; Facchin, G; Fanin, R; Klimko, N; Lazzarotto, D; Melillo, L; Nadali, G; Pagano, L; Perruccio, K; Verga, L; Zannier, ME | 1 |
Moncada, D; Ramírez, I | 1 |
Ding, XL; Liu, LN; Miao, LY; Tian, JX; Xue, L; Yan, HH; Zhang, JJ; Zhang, WJ; Zhang, WW | 1 |
Li, H; Luo, J; Shi, L; Wang, L; Zeng, G; Zhang, Z; Zhu, M | 1 |
Huang, FR; Shen, Y; Sun, LN; Wang, YQ; Zhang, HW; Zhang, XY; Zhou, C | 1 |
Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE | 1 |
Bachellier, P; Bru, V; Gourieux, B; Herbrecht, R; Launoy, A; Levêque, D; Lutun, P; Nivoix, Y; Poulat, C; Rohr, S; Woehl, ML | 1 |
Gueta, I; Halkin, H; Kamari, Y; Livni, G; Loebstein, R; Markovits, N; Yarden-Bilavsky, H | 1 |
Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P | 1 |
Goldraich, L; Husain, S; Kabbani, D; Ross, H; Rotstein, C | 1 |
Asano, S; Kato, K; Sakurada, H; Tachi, T; Teramachi, H; Yamamura, M; Yasuhara, K; Yoshida, M | 1 |
Brizendine, KD; Cober, E; Johnson, L; Nambiar, P | 1 |
Avila, AM; Barba, P; Cho, C; Devlin, S; Huang, YT; Maloy, MA; Montoro, J; Papanicolaou, GA; Perales, MA; Rosillo, C | 1 |
Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L | 1 |
Chauhan, V; Córdoba, R; de Jong, J; De Wilde, S; de Zwart, L; Hellemans, P; Jiao, J; Manikhas, G; Masterson, T; Myasnikov, A; Osmanov, D; Ouellet, D; Panizo, C; Patricia, D; Snoeys, J; Sukbuntherng, J | 1 |
Anderson, A; Lin, T; McManus, D; Perreault, S; Ruggero, M; Topal, JE | 1 |
Bentvelsen, RG; de Haan, AF; Kuiper, EJ; Lestrade, PP; Melchers, WJG; Rijnders, BJA; Schalekamp, S; Schauwvlieghe, AFAD; van der Beek, MT; van der Hoeven, HL; van der Hoven, B; van der Lee, HA; van der Velden, WJFM; van Paassen, J; Verweij, PE | 1 |
Chaftari, AM; Dib, RW; Ghaly, F; Hachem, RY; Jiang, Y; Raad, I | 1 |
Brüggemann, RJ; Hanff, LM; Henriet, S; Koch, BCP; Lempers, VJ; Mavinkurve-Groothuis, AM; Meuwese, E; van der Sluis, IM; Warris, A | 1 |
Fang, JP; Huang, K; Li, Y; Liao, XY; Qiu, KY; Xu, HG; Zhou, DH | 1 |
Bao, F; Hu, K; Liu, Y; Qiu, T; Wang, J; Zhang, C | 1 |
Aram, JA; Chen, X; Jin, J; Liu, Y; Lou, YJ; Meng, H; Pan, S; Patterson, TF; Schwartz, IS; Wu, D; Yan, JL; Zhang, X | 1 |
Cornelissen, JJ; De Kort, E; Lagrou, K; Lestrade, PPA; Maertens, J; Mercier, T; Resendiz-Sharpe, A; Rijnders, BJA; Schauwvlieghe, AFAD; van der Beek, MT; Verweij, PE; von dem Borne, PA | 1 |
Aram, JA; Lee, DG; Lee, HJ; Lin, SS; Yan, JL | 1 |
Bacci, F; Bertuzzi, C; Bonifazi, F; Cavo, M; Cricca, M; De Cicco, G; Lewis, RE; Paolini, S; Sassi, C; Stanzani, M; Sutto, E | 1 |
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H | 1 |
Huitema, AD; Schellens, JH; Schouten-van Meeteren, AY; van Eijkelenburg, NK; van Hasselt, JG | 1 |
Duettmann, W; Fruhwald, S; Hoenigl, M; Krause, R; Prueller, F; Raggam, RB; Seeber, K; Troppan, K; Valentin, T; Wagner, J; Wölfler, A; Zollner-Schwetz, I | 1 |
Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M | 1 |
Gamaletsou, MN; Walsh, TJ | 1 |
Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG | 1 |
Fung, HC; Peksa, GD; Schultz, K | 1 |
Baker, KS; Cornell, C; Englund, JA; Johnson, D; Meshinchi, S; Parnell, S; Tarlock, K | 1 |
Hachem, R; Helou, GE; Jiang, Y; Kontoyiannis, DP; Raad, II; Zakhem, AE | 1 |
Ramos, MG; Rodríguez, ZC | 1 |
Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ | 1 |
Crowe, A; Slavin, MA; Thursky, KA; Trubiano, JA; Worth, LJ | 1 |
Adel, NG; Barker, JN; Castro-Malaspina, H; Ceberio, I; Dai, K; Devlin, SM; Giralt, S; Goldberg, JD; Perales, MA | 1 |
Bow, EJ; Cornely, OA; Heinz, WJ; Herbrecht, R; Jagannatha, S; Koh, LP; Kontoyiannis, DP; Lee, DG; Maertens, JA; Marr, KA; Nucci, M; Pappas, PG; Queiroz-Telles, F; Rottinghaus, ST; Schlamm, HT; Selleslag, D; Slavin, MA; Walsh, TJ; Wingard, JR | 1 |
Cotton, D | 1 |
Bartoli, M; Bulabois, CE; Cahn, JY; Fonrose, X; Gautier-Veyret, E; Quesada, JL; Stanke-Labesque, F; Thiebaut-Bertrand, A; Tonini, J | 1 |
Barajas, MR; Bartoo, GT; Dierkhising, RA; El-Azhary, RA; Hashmi, SK; Hogan, WJ; Litzow, MR; Merten, JA; Patnaik, MM; Plevak, MF; Wilson, JW; Wojenski, DJ; Wolf, RC | 1 |
Biswas, D; Dewan, E; Kakati, B; Kotwal, A; Oberoi, A; Verma, SK | 1 |
Akagi, T; Ishida, Y; Ito, S; Kowata, S; Kubo, K; Murai, K; Oyake, T; Sawada, K | 1 |
da Silva, CM; de Lima Neto, RG; de Morais, VL; Domingos, Ide F; Gonçalves, SS; Leite, EP; Macêdo, DP; Neves, RP; Parahym, AM; Rolim Neto, PJ | 1 |
Cho, EY; Choi, EH; Kang, HJ; Kang, HM; Lee, H; Lee, HJ; Lee, JW; Park, KD; Shin, HY; Yu, KS | 1 |
Bigliardi, S; Candoni, A; Cojutti, P; Fanin, R; Forghieri, F; Isola, M; Luppi, M; Pea, F; Zannier, ME | 1 |
Kimura, S | 1 |
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Han, S; Kim, SH; Kwon, JC; Lee, DG; Lee, HJ; Lee, JW; Park, C; Park, SH; Yim, DS; Yoo, JH | 1 |
Kato, S; Konuma, T; Kurokawa, Y; Takahashi, S; Tojo, A; Yasu, T | 1 |
Cai, S; Guo, X; Ren, J; Yuan, W | 1 |
Aitken, SL; Heo, ST; Kontoyiannis, DP; Tverdek, FP | 1 |
Fujimoto, Y; Ikawa, K; Kanbayashi, Y; Nomura, K; Taniwaki, M | 1 |
Imataki, O; Ishida, T; Kitanaka, A; Kubota, Y; Ohnishi, H; Tanaka, T | 1 |
Caira, M; Fianchi, L; Pagano, L | 1 |
Nawrot, U; Nowicka, J; Wlodarczyk, K | 1 |
Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K | 1 |
Maschmeyer, G | 1 |
Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D | 1 |
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS | 1 |
Lagrou, K; Maertens, J; Meersseman, W; Saegeman, V; Spriet, I; Verbeken, E | 1 |
Clancy, CJ; Cline, C; Jantz, MA; Kulkarni, V; Leather, H; Nguyen, MH; Wheat, LJ; Wingard, JR | 1 |
Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E | 1 |
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS | 1 |
Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H | 1 |
Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L | 1 |
Choi, JH; Choi, SM; Han, S; Kim, SH; Kwon, EY; Kwon, JC; Lee, DG; Park, C; Park, SH; Yim, DS; Yoo, JH | 1 |
Feng, AM; Wei, JY; Yu, WJ | 1 |
Shen, YF; Sun, HL; Zhou, X | 1 |
Bergeron, A; Ferry, C; Lacroix, C; Peffault de Latour, R; Petropoulou, A; Porcher, R; Ribaud, P; Robin, M; Rocha, V; Salmeron, G; Socié, G; Sulahian, A; Xhaard, A | 1 |
Cook, G; Cordonnier, C; Hicheri, Y | 1 |
Choi, SH; Chun, S; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Lee, YJ; Woo, JH | 1 |
Fasler, D; Gerber, B; Guggenberger, R; Manz, MG; Nair, G; Schanz, U; Stussi, G | 1 |
Huang, XE; Shen, ZS; Su, AL; Xu, YL; Zhang, XQ; Zhang, XZ | 1 |
Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A | 1 |
Estes, LL; Wilson, JW; Zeuli, JD | 1 |
Dadwal, SS; Davies-Vorbrodt, S; Ito, JI; Kriengkauykiat, J; Tegtmeier, BR | 1 |
Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L | 1 |
Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH | 1 |
D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
Mehta, J; Ortiz, R; Pennick, G; Pi, J; Stosor, V; Trifilio, S; Verma, A; Zembower, T | 1 |
Böhme, A; Haas, A; Maschmeyer, G | 1 |
Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A | 1 |
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T | 1 |
Björkholm, M; Cherif, H; Kalin, M | 1 |
Klastersky, J; Paesmans, M | 1 |
Bennett, CL; Blum, W; Chamilos, G; Evens, A; Kennedy, L; Kontoyiannis, DP; McKoy, JM; Mehta, J; Mullane, K; Palella, F; Parada, J; Scheetz, MH; Tallman, MS; Trifilio, SM; Yarnold, PR | 1 |
Evens, A; Frankfurt, O; Golf, M; Gordon, L; Kaniecki, K; Mehta, J; Pennick, G; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J; Zook, J | 1 |
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
Cimino, G; Gentile, G; Girmenia, C; Martino, P; Pizzarelli, G; Pozzi, E | 1 |
Arenz, D; Böhme, A; Cornely, OA; Kiehl, MG; Kochanek, M; Pankraz, K; Reichert, D; Ullmann, AJ; Vehreschild, JJ | 1 |
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J | 1 |
Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O | 1 |
Cassone, A; Girmenia, C; Martino, P; Monaco, M; Mondello, F; Santilli, S; Tuccinardi, C | 1 |
Blumer, JL; Lazarus, HM; Romero, A; Schlamm, H; Yanovich, S | 1 |
Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ | 1 |
17 review(s) available for voriconazole and Hematologic Malignancies
Article | Year |
---|---|
How different is invasive fusariosis in pediatric patients than in adults? A systematic review.
Topics: Adult; Antifungal Agents; Child; Fusariosis; Hematologic Neoplasms; Humans; Triazoles; Voriconazole | 2021 |
Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registry.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Hematologic Neoplasms; Humans; Registries; Trichoderma; Voriconazole | 2022 |
Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System; Female; Hematologic Neoplasms; Humans; Mucormycosis; Voriconazole | 2022 |
Recommendations on the use of azole antifungals in hematology-oncology patients.
Topics: Antifungal Agents; Antineoplastic Agents; Azoles; Hematologic Neoplasms; Humans; Voriconazole | 2023 |
Central nervous system fungal infections in allogeneic stem cell transplantation. Outcome of 24 recent cases and literature review.
Topics: Adolescent; Adult; Allografts; Amphotericin B; Central Nervous System Fungal Infections; Child; Disease-Free Survival; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Survival Rate; Voriconazole | 2020 |
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2020 |
Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: Case report and review of Fusarium infections in solid organ transplantation.
Topics: Abdomen; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Fatal Outcome; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Osteomyelitis; Tomography, X-Ray Computed; Transplants; Voriconazole | 2018 |
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature.
Topics: Adult; Aged; Antifungal Agents; Disease Outbreaks; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Saccharomycetales; Voriconazole | 2019 |
Treatment of fungal disease in the setting of neutropenia.
Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole | 2014 |
Invasive Aspergillosis in Hematological Patients.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Biomarkers; Echinocandins; Hematologic Neoplasms; Humans; Neutropenia; Opportunistic Infections; Risk Factors; Stem Cell Transplantation; Tomography, X-Ray Computed; Voriconazole | 2016 |
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole | 2009 |
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Antifungal prophylaxis in haematology patients: the role of voriconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review.
Topics: Body Mass Index; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Obesity; Overweight; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2013 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fever; Hematologic Neoplasms; Humans; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
14 trial(s) available for voriconazole and Hematologic Malignancies
Article | Year |
---|---|
Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients.
Topics: Adolescent; Adult; Aged; Body Weight; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Models, Biological; Reproducibility of Results; Transplantation Conditioning; Voriconazole | 2019 |
A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies.
Topics: Adenine; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Erythromycin; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Piperidines; Polymorphism, Single Nucleotide; Pyrazoles; Pyrimidines; Voriconazole | 2018 |
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole | 2019 |
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Asian People; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Placebos; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2019 |
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Therapy, Combination; Echinocandins; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Male; Mannans; Middle Aged; Platelet Count; Treatment Outcome; Voriconazole; Young Adult | 2015 |
Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Echinocandins; Febrile Neutropenia; Female; Hematologic Diseases; Hematologic Neoplasms; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Treatment Outcome; Voriconazole; Young Adult | 2016 |
Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China.
Topics: Adolescent; Adult; Aged; Antifungal Agents; China; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Survival Rate; Voriconazole; Young Adult | 2016 |
Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
Topics: Adult; Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Aspergillus; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Republic of Korea; Risk Factors; Triazoles; Voriconazole; Young Adult | 2011 |
Phase II study on voriconazole for treatment of Chinese patients with malignant hematological disorders and invasive aspergillosis.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2002 |
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2002 |
80 other study(ies) available for voriconazole and Hematologic Malignancies
Article | Year |
---|---|
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged | 2008 |
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
UPLC-MS/MS method for the determination of voriconazole plasma concentration from pediatric patients with hematologic tumors: An application toward personalized therapy.
Topics: Acetonitriles; Antifungal Agents; Child; Chromatography, High Pressure Liquid; Chromatography, Liquid; Hematologic Neoplasms; Humans; Reproducibility of Results; Tandem Mass Spectrometry; Voriconazole | 2022 |
Evaluation of voriconazole related adverse events in pediatric patients with hematological malignancies.
Topics: Antifungal Agents; Child; Hematologic Neoplasms; Humans; Prospective Studies; Retrospective Studies; Voriconazole | 2023 |
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.
Topics: Adult; Antifungal Agents; Bayes Theorem; China; Hematologic Neoplasms; Humans; Models, Biological; Triazoles; Voriconazole | 2022 |
Impact of Inflammation on Intra-individual Variation in Trough Voriconazole Concentration in Patients with Hematological Malignancies.
Topics: Antifungal Agents; C-Reactive Protein; Drug Monitoring; Hematologic Neoplasms; Humans; Inflammation; Retrospective Studies; Voriconazole | 2022 |
Dosage optimization of voriconazole in children with haematological malignancies based on population pharmacokinetics.
Topics: Antifungal Agents; Child; Cytochrome P-450 CYP2C19; Hematologic Neoplasms; Humans; Retrospective Studies; Voriconazole | 2022 |
Fusariosis in Mexico: A 10-year retrospective series.
Topics: Amphotericin B; Antifungal Agents; Burns; Febrile Neutropenia; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Mexico; Retrospective Studies; Voriconazole | 2023 |
Epidemiological aspects and characterization of the resistance profile of
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Child; Child, Preschool; Female; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Voriconazole; Young Adult | 2019 |
Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.
Topics: Adult; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mortality; Retrospective Studies; Survival Rate; Voriconazole | 2019 |
Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms.
Topics: Antifungal Agents; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pharmacogenetics; Polymorphism, Single Nucleotide; Pregnane X Receptor; Procalcitonin; Retrospective Studies; Voriconazole | 2020 |
Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies.
Topics: Antifungal Agents; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Genotype; Hematologic Neoplasms; Humans; Tandem Mass Spectrometry; Voriconazole | 2021 |
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
Assessment of high-priced systemic antifungal prescriptions.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Middle Aged; Multiple Organ Failure; Mycoses; Organ Transplantation; Retrospective Studies; Survival Rate; Treatment Outcome; Voriconazole; Young Adult | 2017 |
Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors.
Topics: Adult; Antifungal Agents; Electrocardiography; Female; Hematologic Neoplasms; Humans; Hypokalemia; Long QT Syndrome; Male; Middle Aged; Risk Factors; Voriconazole | 2017 |
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Asymptomatic Diseases; Cohort Studies; Disease Outbreaks; Echinocandins; Female; Galactose; Heart Transplantation; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Mass Screening; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplant Recipients; Voriconazole | 2018 |
An investigation of visual hallucinations associated with voriconazole administration to patients with hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hallucinations; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Vision Disorders; Voriconazole | 2016 |
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Echinocandins; Female; Fungi; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Invasive Fungal Infections; Lipopeptides; Male; Micafungin; Middle Aged; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2018 |
Evaluating a voriconazole dose modification guideline to optimize dosing in patients with hematologic malignancies.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Body Mass Index; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Practice Guidelines as Topic; Prospective Studies; Voriconazole; Young Adult | 2019 |
Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Autoimmune Diseases; Child; Child, Preschool; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Analysis; Time Factors; Voriconazole | 2019 |
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Empiricism; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Precision Medicine; Prognosis; Retrospective Studies; Standard of Care; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Male; Retrospective Studies; Serum; Voriconazole | 2019 |
Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Male; Mycoses; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Voriconazole | 2019 |
Model-based Voriconazole Dose Optimization in Chinese Adult Patients With Hematologic Malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; China; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Middle Aged; Models, Statistical; Prospective Studies; Voriconazole; Young Adult | 2019 |
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Drug Therapy, Combination; Female; Fungal Proteins; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Mutation; Prevalence; Prognosis; Retrospective Studies; Survival Analysis; Voriconazole | 2019 |
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.
Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis; Cheilitis; Child; Child, Preschool; Dermatitis, Photoallergic; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Male; Methotrexate; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2015 |
Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole.
Topics: Adult; Antifungal Agents; Bone Diseases; Child; Child, Preschool; Combined Modality Therapy; Female; Fluorides; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Periostitis; Prognosis; Transplant Recipients; Voriconazole; Young Adult | 2015 |
Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2015 |
Acremonium species associated fungemia: a novel pathogen in the immunosuppressed patient.
Topics: Acremonium; Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Treatment Outcome; Voriconazole | 2014 |
Putting CYP2C19 genotyping to the test: utility of pharmacogenomic evaluation in a voriconazole-treated haematology cohort.
Topics: Aged; Antifungal Agents; Cohort Studies; Cytochrome P-450 CYP2C19; Female; Genotyping Techniques; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pharmacogenetics; Pilot Projects; Treatment Outcome; Voriconazole | 2015 |
Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antifungal Agents; Drug Interactions; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Sirolimus; Transplantation, Homologous; Voriconazole; Young Adult | 2015 |
Celebrating the ACP centennial: from the annals archive.
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Voriconazole | 2015 |
Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels.
Topics: Adult; Antifungal Agents; Aspergillosis; Cytochrome P-450 Enzyme System; Diarrhea; Drug Interactions; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Individuality; Male; Middle Aged; Polymorphism, Genetic; Proton Pump Inhibitors; Voriconazole | 2015 |
Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Skin Neoplasms; Transplantation, Homologous; Voriconazole; Young Adult | 2015 |
Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India.
Topics: Amphotericin B; Candida albicans; Candida tropicalis; Candidemia; Cross-Sectional Studies; Female; Hematologic Neoplasms; Humans; India; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nystatin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prevalence; Risk Factors; Tertiary Care Centers; Voriconazole | 2015 |
Invasive infection due to Saprochaete capitata in a young patient with hematological malignancies.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Lung; Male; Microbial Sensitivity Tests; Microbiological Techniques; Microscopy; Radiography, Thoracic; Saccharomycetales; Treatment Outcome; Voriconazole | 2015 |
The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections.
Topics: Adolescent; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Organ Transplantation; Time Factors; Voriconazole | 2015 |
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Italy; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Treatment Outcome; Voriconazole | 2016 |
Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
Topics: Administration, Intravenous; Adolescent; Adult; Antifungal Agents; Aspergillosis; beta-Cyclodextrins; Creatinine; Cytochrome P-450 CYP2C19; Drug Compounding; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Voriconazole; Young Adult | 2016 |
Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Body Weight; Bone Marrow Transplantation; Cord Blood Stem Cell Transplantation; Drug Interactions; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Injections, Intravenous; Lansoprazole; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Postoperative Complications; Rabeprazole; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Voriconazole; Young Adult | 2016 |
How common is subsequent central nervous system toxicity in asymptomatic patients with haematologic malignancy and supratherapeutic voriconazole serum levels?
Topics: Adult; Age Factors; Aged; Antifungal Agents; Central Nervous System; Cognitive Dysfunction; Consciousness Disorders; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Vision Disorders; Voriconazole | 2017 |
Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2008 |
Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hallucinations; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
Pulmonary aspergillosis in hematologic malignancies: lights and shadows.
Topics: Antifungal Agents; Aspergillosis; Hematologic Neoplasms; Humans; Lung Diseases; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2008 |
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms; Humans; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Increasing incidence of mucormycosis in University Hospital, Belgium.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Belgium; Child; Female; Hematologic Neoplasms; Hospitals, University; Humans; Incidence; Male; Middle Aged; Mucormycosis; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult | 2010 |
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Triazoles; Voriconazole | 2011 |
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole | 2011 |
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2011 |
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole | 2011 |
[Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cause of Death; Child; Child, Preschool; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Voriconazole; Young Adult | 2012 |
Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies.
Topics: Adult; Aged; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Republic of Korea; Tertiary Care Centers; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
Topics: Adult; Antifungal Agents; Bone Diseases; Female; Fluorides; Hematologic Neoplasms; Humans; Itraconazole; Middle Aged; Muscle, Skeletal; Periostitis; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2012 |
The surgical management of rhinocerebral mucormycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole | 2003 |
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
Topics: Alkaline Phosphatase; Antifungal Agents; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Premedication; Pyrimidines; Retrospective Studies; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2006 |
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2007 |
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Graft Rejection; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Aspergillosis; Child; Cohort Studies; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole | 2008 |
[Rare pulmonary mycoses in patients with hematologic diseases].
Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 1998 |
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |